TMEFF1 and age-related macular degeneration: On the other hand, the number of TCCR/WSX-1, transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1/Tomoregulin-1), and u-plasminogen activator (uPA) were increased in patients with AMD (Figure 1C).